# LXN

## Overview
The LXN gene encodes the protein latexin, which functions as an endogenous carboxypeptidase inhibitor. This protein is primarily involved in regulating protease activity and is expressed in various tissues, including the brain and hematopoietic cells. Latexin plays a crucial role in modulating inflammation, cell proliferation, and differentiation, and is active in the cytoplasm, influencing immune response and tissue homeostasis. It is categorized as a regulatory protein due to its involvement in these processes. In addition to its physiological roles, latexin has been implicated in cancer biology, particularly as a potential tumor suppressor in prostate cancer, and in inflammatory conditions such as inflammatory bowel disease (Li2020Latexin; You2014Latexin; Seed2019The).

## Function
Latexin (LXN) is a protein that functions as an endogenous carboxypeptidase inhibitor, primarily involved in regulating protease activity. It is expressed in various tissues, including the brain and hematopoietic cells, and plays a significant role in modulating inflammation, cell proliferation, and differentiation. LXN is active in the cytoplasm and may influence organismal outcomes such as immune response and tissue homeostasis (You2014Latexin; Seed2019The).

In prostate epithelial cells, LXN is highly expressed in normal luminal cells and is secreted into the extracellular space. It is downregulated in high-grade cancers, suggesting a potential tumor suppressor role. LXN is involved in retinoid signaling and inflammatory pathways, indirectly affecting genes related to immune cell function and inflammatory processes (Seed2019The).

LXN also interacts with the Rps3 protein, a component of the 40S ribosomal subunit, influencing DNA damage response and cell-cycle regulation. This interaction sequesters Rps3 in the cytoplasm, reducing its nuclear translocation, which can lead to cell-cycle arrest and increased sensitivity to radiation and chemotherapy in cancer cells (You2014Latexin).

## Clinical Significance
Latexin (LXN) has been implicated in various inflammatory conditions, particularly in the context of inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease. Alterations in LXN expression can exacerbate colitis, as demonstrated in mouse models where LXN deficiency leads to more severe symptoms of colitis, such as rapid weight loss, severe bloody stools, and increased levels of inflammatory cytokines like TNF-α, IL-1β, and IL-6 (Li2020Latexin). LXN interacts with the HECTD1/Rps3/NF-κB pathway, and its deficiency enhances the interaction between HECTD1 and Rps3, promoting the degradation of IκBα and increasing inflammation (Li2020Latexin).

LXN is also necessary for the therapeutic effects of retinoic acid in treating colitis. Retinoic acid increases LXN expression, which reduces the inflammatory response by disrupting the interaction between Rps3 and HECTD1, thereby decreasing the ubiquitylation of IκBα and inhibiting NF-κB activation (Li2020Latexin). These findings suggest that targeting LXN expression or its interactions could be a novel strategy for treating inflammatory conditions like colitis (Li2020Latexin).

## Interactions
Latexin (LXN) is involved in several protein interactions that influence various cellular processes. LXN interacts with ribosomal protein subunit 3 (Rps3), a protein involved in DNA damage response and NF-κB signaling pathways. This interaction has been confirmed through co-immunoprecipitation and immunocytochemical staining, showing colocalization in the cytoplasm of leukemogenic cells (You2014Latexin). LXN also forms a complex with HECTD1, an E3 ubiquitin ligase, and Rps3, which influences the ubiquitylation of IκBα, a key regulator of the NF-κB pathway. This interaction is crucial for modulating inflammatory responses, as LXN competes with HECTD1 for binding to Rps3, thereby stabilizing IκBα and inhibiting NF-κB activation (Li2020Latexin).

In the context of macrophage function, LXN interacts with JAK1 and STAT3, forming a complex that suppresses the JAK1/STAT3 signaling pathway. This interaction is significant in regulating macrophage polarization and PD-L2 expression, which are important for immune responses and tumor immune modulation (Li2022Loss). These interactions highlight LXN's role in regulating inflammation, immune responses, and cell cycle progression through its binding with various proteins.


## References


[1. (Li2020Latexin) Yaping Li, Baohua Huang, Hua Yang, Shuang Kan, Yanling Yao, Xin Liu, Shiming Pu, Guozhang He, Taj-Malook Khan, Guangying Qi, Zuping Zhou, Wei Shu, and Ming Chen. Latexin deficiency in mice up-regulates inflammation and aggravates colitis through hectd1/rps3/nf-κb pathway. Scientific Reports, June 2020. URL: http://dx.doi.org/10.1038/s41598-020-66789-x, doi:10.1038/s41598-020-66789-x. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-66789-x)

[2. (You2014Latexin) Y You, R Wen, R Pathak, A Li, W Li, D St Clair, M Hauer-Jensen, D Zhou, and Y Liang. Latexin sensitizes leukemogenic cells to gamma-irradiation-induced cell-cycle arrest and cell death through rps3 pathway. Cell Death &amp; Disease, 5(10):e1493–e1493, October 2014. URL: http://dx.doi.org/10.1038/cddis.2014.443, doi:10.1038/cddis.2014.443. This article has 15 citations.](https://doi.org/10.1038/cddis.2014.443)

[3. (Li2022Loss) Yaping Li, Yanhui Tan, XiuZhen Li, Xuanming Chen, Lingzhu Wang, Lijun Zhang, Shaohua Xu, Kebing Huang, Wei Shu, Hong Liang, and Ming Chen. Loss of lxn promotes macrophage m2 polarization and pd-l2 expression contributing cancer immune-escape in mice. Cell Death Discovery, November 2022. URL: http://dx.doi.org/10.1038/s41420-022-01227-7, doi:10.1038/s41420-022-01227-7. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-022-01227-7)

[4. (Seed2019The) Robert I. Seed, Alberto J. Taurozzi, Daniel J. Wilcock, Giovanna Nappo, Holger H. H. Erb, Martin L. Read, Mark Gurney, Leanne K. Archer, Saburo Ito, Martin G. Rumsby, John L. Petrie, Aled Clayton, Norman J. Maitland, and Anne T. Collins. The putative tumour suppressor protein latexin is secreted by prostate luminal cells and is downregulated in malignancy. Scientific Reports, March 2019. URL: http://dx.doi.org/10.1038/s41598-019-41379-8, doi:10.1038/s41598-019-41379-8. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-41379-8)